Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...

Local Anesthetics: Differential Sensitivity of Nerve Fibers

Local Anesthetics: Differential Sensitivity of Nerve Fibers

Local anesthetics (LAs) block the sodium channels of nerve trunks, sensory nerve endings, and neuromuscular junctions. Although LAs can block all kinds of nerves, the sensitivity of nerve fibers differs according to nerve types and structures. LAs are known to block myelinated fibers faster than unmyelinated ones. Also, they block pain or sensory neurons at low concentrations without affecting the motor neurons involved in muscle contractions. This helps relieve labor pain without affecting the...

Myasthenia Gravis: Diagnostic Tests

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Safety analysis and complications of condylar screws in a single-surgeon series of 250 occipitocervical fusions.

Acta neurochirurgica·2021

Same author

Pathogenesis and Classification of Chiari Malformation Type I Based on the Mechanism of Ptosis of the Brain Stem and Cerebellum: A Morphometric Study of the Posterior Cranial Fossa and Craniovertebral Junction.

Journal of neurological surgery. Part B, Skull base·2021

Same author

Surgical Management of Chiari Malformations: Preliminary Results of Surgery According to the Mechanisms of Ptosis of the Brain Stem and Cerebellum.

Journal of neurological surgery. Part B, Skull base·2021

Same author

Professional Profiles, Technical Preferences, Surgical Opinions, and Management of Clinical Scenarios from a Panel of 63 International Experts in the Field of Chiari I Malformation.

World neurosurgery·2020

Same author

Chiari I Malformation: Opinions on Diagnostic Trends and Controversies from a Panel of 63 International Experts.

World neurosurgery·2019

Same author

Development of Common Data Elements for Use in Chiari Malformation Type I Clinical Research: An NIH/NINDS Project.

Neurosurgery·2019

Search research articles

Related Experiment Video

Updated: Jun 4, 2026

Screening of Axonal Degeneration in Carpal Tunnel Syndrome Using Ultrasonography and Nerve Conduction Studies

Screening of Axonal Degeneration in Carpal Tunnel Syndrome Using Ultrasonography and Nerve Conduction Studies

Published on: January 11, 2019

Upper leg conduction time distinguishes demyelinating neuropathies.

Paul J Maccabee¹, Larry P Eberle, Ian A G Stein

¹Department of Neurology, Robert F. Furchgott Center for Neural and Behavioral Science, SUNY Downstate Medical Center, 450 Clarkson Avenue, Brooklyn, New York 11203, USA. paul.maccabee@downstate.edu

|February 15, 2011

Summary

Comparing nerve conduction time changes in specific peripheral nerve segments effectively differentiates demyelinating from axonal neuropathies, aiding in diagnosing various nerve conditions.

More Related Videos

In Vivo Electrophysiological Measurement of Compound Muscle Action Potential from the Forelimbs in Mouse Models of Motor Neuron Degeneration

In Vivo Electrophysiological Measurement of Compound Muscle Action Potential from the Forelimbs in Mouse Models of Motor Neuron Degeneration

Published on: June 15, 2018

In Vivo Electrophysiological Measurement of the Rat Ulnar Nerve with Axonal Excitability Testing

In Vivo Electrophysiological Measurement of the Rat Ulnar Nerve with Axonal Excitability Testing

Published on: February 6, 2018

Related Experiment Videos

Last Updated: Jun 4, 2026

Screening of Axonal Degeneration in Carpal Tunnel Syndrome Using Ultrasonography and Nerve Conduction Studies

Screening of Axonal Degeneration in Carpal Tunnel Syndrome Using Ultrasonography and Nerve Conduction Studies

Published on: January 11, 2019

In Vivo Electrophysiological Measurement of Compound Muscle Action Potential from the Forelimbs in Mouse Models of Motor Neuron Degeneration

In Vivo Electrophysiological Measurement of Compound Muscle Action Potential from the Forelimbs in Mouse Models of Motor Neuron Degeneration

Published on: June 15, 2018

In Vivo Electrophysiological Measurement of the Rat Ulnar Nerve with Axonal Excitability Testing

In Vivo Electrophysiological Measurement of the Rat Ulnar Nerve with Axonal Excitability Testing

Published on: February 6, 2018

Area of Science:

Neuroscience
Clinical Electrophysiology

Background:

Peripheral neuropathies are broadly classified as demyelinating or axonal.
Accurate differentiation is crucial for effective treatment and prognosis.
Current diagnostic methods may face challenges in distinguishing these types, especially with reduced nerve signal amplitudes.

Purpose of the Study:

To investigate if analyzing conduction time changes in defined peripheral nerve segments can improve the differentiation between demyelinating and axonal neuropathies.
To assess the utility of segmental conduction time analysis in a diverse patient cohort.

Main Methods:

Compound muscle action potentials (CMAPs) were recorded from lower limb muscles.
Tibial nerve stimulation was performed at the ankle and popliteal fossa.
Paravertebral neuromagnetic stimulation of the cauda equina was utilized.
Segmental conduction times were calculated and compared across various neuropathy patient groups and healthy controls.

Main Results:

Segmental conduction times, particularly in the upper leg and cauda equina, along with distal cauda equina latency and CMAP duration, proved effective in distinguishing demyelinating from axonal neuropathies.
This differentiation was achievable even when CMAP amplitudes were reduced.

Conclusions:

Segmental conduction time analysis offers a valuable method for differentiating between demyelinating and axonal neuropathies.
The study successfully distinguished subtypes within the demyelinating neuropathy spectrum.